Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 4/20 | 0.42 |
| ▸ | DAO | P14920 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 6/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28520033 | 0.85 | MAOB (0.41) | ENPP2DAOMAOBNR4A2 | |
| SCHEMBL28529096 | 0.85 | NPC1 (0.42) | ENPP2MAOBPARP10MAPTL3MBTL1 | |
| SCHEMBL28520513 | 0.84 | CA1 (0.41) | ENPP2DAOMAPTL3MBTL1 | |
| SCHEMBL28530298 | 0.82 | ENPP2 (0.46) | ENPP2MAOBMAPT | |
| SCHEMBL28908256 | 0.79 | MRGPRX4 (0.41) | ENPP2DAOMAPTL3MBTL1 | |
| SCHEMBL28521411 | 0.75 | ENPP2 (0.51) | ENPP2MAOBAPP | |
| SCHEMBL28534898 | 0.75 | ENPP2 (0.48) | ENPP2MAOB | |
| SCHEMBL28519499 | 0.74 | RXRA (0.40) | ENPP2MAPTL3MBTL1 | |
| SCHEMBL28521420 | 0.74 | ALDH1A1 (0.45) | ENPP2APPMAPTL3MBTL1 | |
| SCHEMBL2345827 | 0.72 | MAOB (0.61) | ENPP2MAOBAPPNR4A2PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108602834-B | Bruton's tyrosine kinase inhibitor | 北京盛诺基医药科技股份有限公司 | 2021-01-08 | — | — | CN | disclosed |